Free Trial

Johnson & Johnson (JNJ) SEC Filings & 10K Form

Johnson & Johnson logo
$163.63 +0.50 (+0.31%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$163.36 -0.27 (-0.17%)
As of 03/28/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Johnson & Johnson SEC Filings

DateFilerForm TypeView
03/20/2025
1:00 PM
Johnson & Johnson (Subject)
Mercy Investment Services, Inc. (Filed by)
Form PX14A6G
03/19/2025
7:07 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
5:44 AM
Johnson & Johnson (Filer)
Form ARS
03/12/2025
5:48 AM
Johnson & Johnson (Filer)
Form DEFA14A
03/12/2025
5:40 AM
Johnson & Johnson (Filer)
Form DEF 14A
03/07/2025
4:01 PM
Intra-Cellular Therapies, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
03/06/2025
3:42 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
6:05 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/28/2025
10:43 AM
Johnson & Johnson (Filer)
Form CERT
02/26/2025
5:42 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:22 PM
Johnson & Johnson (Filer)
Form 8-A12B
02/26/2025
3:23 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
4:21 PM
Intra-Cellular Therapies, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
02/25/2025
2:05 PM
Decker Robert J (Reporting)
Johnson & Johnson (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:28 PM
Johnson & Johnson (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/20/2025
4:26 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
4:37 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:44 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:25 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:27 PM
Johnson & Johnson (Issuer)
Mulholland Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:29 PM
Johnson & Johnson (Issuer)
REED JOHN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:31 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:33 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:35 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:16 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:18 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:22 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:07 PM
Johnson & Johnson (Subject)
Form FWP
02/19/2025
4:11 PM
Johnson & Johnson (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/19/2025
5:04 AM
Johnson & Johnson (Filer)
Form 424B5
02/18/2025
8:46 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:33 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:13 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:16 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:01 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:02 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:03 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:05 PM
Johnson & Johnson (Issuer)
Mulholland Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:06 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:08 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:11 PM
Johnson & Johnson (Issuer)
REED JOHN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)

If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.

02/18/2025
7:58 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:09 AM
Johnson & Johnson (Filer)
Form 424B5
02/13/2025
2:10 PM
Johnson & Johnson (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/12/2025
5:32 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:35 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:37 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:38 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:10 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:18 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:21 PM
Johnson & Johnson (Issuer)
Mulholland Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:53 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:07 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:38 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
6:40 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
6:41 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
6:42 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
6:43 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
12:27 PM
Johnson & Johnson (Subject)
Wolk Joseph J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
4:25 PM
Intra-Cellular Therapies, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/22/2025
3:55 PM
Johnson & Johnson (Filer)
Form 8-K/A
01/22/2025
5:35 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
4:27 PM
Intra-Cellular Therapies, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
12/12/2024
4:16 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:27 PM
Johnson & Johnson (Issuer)
WEINBERGER MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:09 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
12:25 PM
Hait William (Reporting)
Johnson & Johnson (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
8:23 AM
Johnson & Johnson (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
11/01/2024
10:05 AM
CVRx, Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G/A
10/31/2024
4:57 PM
Johnson & Johnson (Issuer)
REED JOHN C (Reporting)
Form 4/A
10/23/2024
3:02 PM
Johnson & Johnson (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/21/2024
5:18 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:23 PM
Johnson & Johnson (Filed by)
Rapport Therapeutics, Inc. (Subject)
Form SC 13G
10/18/2024
3:47 PM
Johnson & Johnson (Filed by)
MeiraGTx Holdings plc (Subject)
Form SC 13G/A
10/15/2024
3:39 PM
DAVIS D SCOTT (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
6:37 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:07 PM
Johnson & Johnson (Issuer)
Mulholland Kristen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2024
3:19 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
3:43 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:44 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:26 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
3:48 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
1:05 PM
Johnson & Johnson (Filer)
Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company  
08/26/2024
3:26 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:35 PM
Johnson & Johnson (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
07/30/2024
8:06 PM
Johnson & Johnson (Filed by)
Rallybio Corp (Subject)
Form SC 13G
07/25/2024
3:02 PM
Johnson & Johnson (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2024
7:14 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
4:48 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:18 PM
Johnson & Johnson (Filer)
Form 11-K/A
06/24/2024
3:43 PM
Johnson & Johnson (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

06/24/2024
3:42 PM
Johnson & Johnson (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/06/2024
4:07 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:07 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:10 PM
Johnson & Johnson (Filer)
Form SD
Specialized Disclosure Report  
05/21/2024
9:43 AM
Johnson & Johnson (Filer)
Form CERT
05/20/2024
4:17 PM
Johnson & Johnson (Filed by)
Kenvue Inc. (Subject)
Form SC 13G/A
05/20/2024
3:34 PM
Johnson & Johnson (Filer)
Form 8-A12B
05/20/2024
8:31 AM
Johnson & Johnson (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
05/17/2024
10:21 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:JNJ) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners